Search Results - "GUTMANN, Edward J"

Refine Results
  1. 1
  2. 2

    The potential utility of re-mining results of somatic mutation testing: KRAS status in lung adenocarcinoma by Biernacka, Anna, Tsongalis, Peter D, Peterson, Jason D, de Abreu, Francine B, Black, Candice C, Gutmann, Edward J, Liu, Xiaoying, Tafe, Laura J, Amos, Christopher I, Tsongalis, Gregory J

    Published in Cancer genetics (01-05-2016)
    “…Abstract KRAS mutant non-small cell lung cancers (NSCLCs) vary in clinical outcome depending on which specific KRAS mutation is present. Shorter progression…”
    Get full text
    Journal Article
  3. 3

    Uncovering additional predictors of urothelial carcinoma from voided urothelial cell clusters through a deep learning–based image preprocessing technique by Levy, Joshua J., Liu, Xiaoying, Marotti, Jonathan D., Kerr, Darcy A., Gutmann, Edward J., Glass, Ryan E., Dodge, Caroline P., Suriawinata, Arief A., Vaickus, Louis J.

    Published in Cancer cytopathology (01-01-2023)
    “…Background Urine cytology is commonly used as a screening test for high‐grade urothelial carcinoma for patients with risk factors or hematuria and is an…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The Pathologist Pipeline: A Brief Look at the "Other End" by Gutmann, Edward J

    “…Recent reports, however, document present or impending shortages of pathologists nationally1 and internationally.2 Proposed solutions to the workforce problem…”
    Get full text
    Journal Article
  6. 6

    Pathologist-Patient Visits—Revisited by Gutmann, Edward J.

    Published in The American journal of surgical pathology (01-08-2022)
    “…Direct pathologist-patient encounters are infrequent, but there has been a modest movement toward such interactions in the past 2 decades. The present article…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Pathology Grand Rounds in a postpandemic world by Gutmann, Edward J.

    Published in Cancer cytopathology (01-12-2021)
    “…Virtual academic talks, including Grand Rounds lectures, became common during the coronavirus disease 2019 pandemic. As pathology departments now consider…”
    Get full text
    Journal Article
  9. 9

    Something’s lost, but something’s gained: On‐site evaluation, telecytology, and the cytopathologist by Gutmann, Edward J.

    Published in Cancer cytopathology (01-04-2019)
    “…The use of telecytology for rapid on‐site evaluation (ROSE) can have benefits, but may create losses as well. While acknowledging the potential benefits, this…”
    Get full text
    Journal Article
  10. 10

    The doctors' lot by Gutmann, Edward J.

    Published in Cancer cytopathology (01-12-2020)
    “…Establishing and maintaining collegial relationships among physicians and other health professionals is challenging. However, these relationships are important…”
    Get full text
    Journal Article
  11. 11

    Rare immune-related adverse events in a patient with metastatic melanoma: a case report highlighting sarcoidosis-like reactions triggered by immune-checkpoint inhibitors by Cao, Yuanzhen, Afzal, Muhammad Zubair, Gutmann, Edward J, Shirai, Keisuke

    Published in Melanoma research (01-02-2024)
    “…Pembrolizumab and ipilimumab/nivolumab (ipi/nivo) combination are FDA-approved immune checkpoint inhibitor (ICI) therapies for metastatic melanoma. ICIs could…”
    Get full text
    Journal Article
  12. 12

    Guar beans in a peritoneal fluid sample by Gutmann, Edward J., Marotti, Jonathan D.

    Published in Cytopathology (Oxford) (01-05-2024)
    “…We report a case of guar beans in a peritoneal fluid sample and describe the thought process that enabled us to make sense of this previously unreported…”
    Get full text
    Journal Article
  13. 13

    GRAND(ER) ROUNDS: Expanding the universe of topics and speakers in a pathology department seminar series by Gutmann, Edward J.

    Published in Annals of diagnostic pathology (01-08-2018)
    “…This article reports on a unique pathology department seminar series that included talks on social science and humanities topics in addition to traditional…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Ships that pass in the night: The cancer cytopathologist and the patient – caring and communication by Gutmann, Edward J.

    Published in Cancer cytopathology (01-06-2017)
    “…This article discusses the caring relationship between the cancer cytopathologist and the patient, as well as the cytopathologist's communication with…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Cytologic features of a case of mixed medullary and follicular cell‐derived thyroid carcinoma with review of the literature by Chambers, Meagan, Tafe, Laura J., Gutmann, Edward J., Kerr, Darcy A.

    Published in Diagnostic cytopathology (01-03-2021)
    “…Mixed medullary and follicular cell‐derived thyroid carcinoma (MMFTC) is a rare primary thyroid carcinoma with morphologic and immunophenotypic evidence of…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Metastatic gastrointestinal stromal tumour in pleural fluid 19 years after initial diagnosis by Rodrigues Simoes, Nathalie J., Coconubo, Daniel Martinez, Dunn, Danielle R., Gutmann, Edward J.

    Published in Cytopathology (Oxford) (01-01-2024)
    “…Gastrointestinal stromal tumours (GISTs) are rarely encountered in pleural fluid samples. We report a case of GIST metastatic to pleural fluid almost two…”
    Get full text
    Journal Article
  20. 20

    MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma by PREIS, Meir, GARDNER, Timothy B, GORDON, Stuart R, PIPAS, J. Marc, MACKENZIE, Todd A, KLEIN, Erin E, LONGNECKER, Daniel S, GUTMANN, Edward J, SEMPERE, Lorenzo F, KORC, Murray

    Published in Clinical cancer research (01-09-2011)
    “…Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy. Diagnosis and management of PDAC are hampered by the absence of sensitive and specific disease…”
    Get full text
    Journal Article